DE69704206D1 - Selbst-replizierende episomale expressionsvektoren, welche gewebespezifische expression vermitteln - Google Patents

Selbst-replizierende episomale expressionsvektoren, welche gewebespezifische expression vermitteln

Info

Publication number
DE69704206D1
DE69704206D1 DE69704206T DE69704206T DE69704206D1 DE 69704206 D1 DE69704206 D1 DE 69704206D1 DE 69704206 T DE69704206 T DE 69704206T DE 69704206 T DE69704206 T DE 69704206T DE 69704206 D1 DE69704206 D1 DE 69704206D1
Authority
DE
Germany
Prior art keywords
self
expression
tissue
expression vectors
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69704206T
Other languages
English (en)
Other versions
DE69704206T2 (de
Inventor
Michael Antoniou
Geradus Grosveld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9617214.3A external-priority patent/GB9617214D0/en
Application filed by Medical Research Council filed Critical Medical Research Council
Application granted granted Critical
Publication of DE69704206D1 publication Critical patent/DE69704206D1/de
Publication of DE69704206T2 publication Critical patent/DE69704206T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16241—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Ceramics (AREA)
  • Telephonic Communication Services (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69704206T 1996-08-16 1997-08-18 Selbst-replizierende episomale expressionsvektoren, welche gewebespezifische expression vermitteln Expired - Fee Related DE69704206T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9617214.3A GB9617214D0 (en) 1996-08-16 1996-08-16 Vector
US2504096P 1996-08-28 1996-08-28
PCT/GB1997/002213 WO1998007876A2 (en) 1996-08-16 1997-08-18 Self-replicating episomal expression vectors conferring tissue-specific gene expression

Publications (2)

Publication Number Publication Date
DE69704206D1 true DE69704206D1 (de) 2001-04-12
DE69704206T2 DE69704206T2 (de) 2001-08-30

Family

ID=26309883

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69704206T Expired - Fee Related DE69704206T2 (de) 1996-08-16 1997-08-18 Selbst-replizierende episomale expressionsvektoren, welche gewebespezifische expression vermitteln

Country Status (11)

Country Link
EP (1) EP0918874B1 (de)
JP (1) JP2000516472A (de)
AT (1) ATE199570T1 (de)
AU (1) AU725474B2 (de)
CA (1) CA2263796A1 (de)
DE (1) DE69704206T2 (de)
DK (1) DK0918874T3 (de)
ES (1) ES2157084T3 (de)
GR (1) GR3035838T3 (de)
PT (1) PT918874E (de)
WO (1) WO1998007876A2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999021979A1 (en) * 1997-10-28 1999-05-06 Maxygen, Inc. Human papillomavirus vectors
US6689606B2 (en) 1998-07-21 2004-02-10 M.L. Laboratories Plc Polynucleotide
KR100795626B1 (ko) 1998-07-21 2008-01-17 코브라 바이오매뉴팩쳐링 피엘씨. 도처에 있는 염색질 개방 요소(유씨오이)를 포함하는폴리뉴클레오티드
US6417002B1 (en) * 1999-02-11 2002-07-09 Pharmacopeia, Inc. Method for maintenance and selection of episomes
DE19942149A1 (de) * 1999-09-03 2001-03-15 Daniele Zink Verfahren zur Expression von exogenen Sequenzen in Säugerzellen
JP2004500097A (ja) 2000-03-02 2004-01-08 エムエル　ラボラトリーズ　ピーエルシー Ｔｃｆ応答性エレメント
AU2001290067B2 (en) 2000-09-20 2007-04-05 Emd Millipore Corporation Artificial ubiquitous chromatin opening elements (UCOE)
US7812148B2 (en) 2001-04-05 2010-10-12 Millipore Corporation Vectors comprising CpG islands without position effect varigation and having increased expression
JP2005500019A (ja) 2001-04-05 2005-01-06 エムエル ラボラトリーズ ピーエルシー 改良された遺伝子発現
JP5016779B2 (ja) * 2001-05-03 2012-09-05 フィット バイオテク オーワイ 発現ベクターおよびその使用方法
FI116851B (fi) 2001-05-03 2006-03-15 Fit Biotech Oyj Plc Ilmentämisvektori, sen käyttöjä ja menetelmä sen valmistamiseksi sekä sitä sisältäviä tuotteita
GB2389115B (en) 2001-12-14 2005-03-16 Asterion Ltd Polypeptide having a plurality of modified growth hormone receptor binding domains of growth hormone
CA2487206A1 (en) 2002-10-07 2004-04-15 Ludwig Institute Cancer Research P53 binding polypeptide
ES2345335T3 (es) 2003-02-01 2010-09-21 Millipore Corporation Elementos geneticos mejorados que proporcionan altos niveles de expresion.
FI116068B (fi) 2003-09-15 2005-09-15 Fit Biotech Oyj Plc Uusi selektiojärjestelmä, siinä käyttökelpoinen vektori, bakteerisolukantoja sekä menetelmä solujen valikoimiseksi
GB0328690D0 (en) 2003-12-10 2004-01-14 Ludwig Inst Cancer Res Tumour suppressor protein
GB0406330D0 (en) * 2004-03-20 2004-04-21 Univ Sheffield Gene screen
GB0509965D0 (en) 2005-05-17 2005-06-22 Ml Lab Plc Improved expression elements
US8058027B2 (en) 2007-01-08 2011-11-15 Millipore Corporation Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants
DK2571998T3 (en) * 2010-05-19 2017-09-25 Icosagen Cell Factory Oü METHOD AND KIT FOR IDENTIFICATION OF CHEMICAL COMPOUNDS MADE TO INHIBIT HUMAN PAPILLOMA VIRUS REPLICATION
JP5863338B2 (ja) 2011-08-25 2016-02-16 株式会社東芝 プラスミド型ベクター、遺伝子プロモーター活性の検出方法、及びアッセイキット
WO2015160928A2 (en) 2014-04-15 2015-10-22 University Of Virginia Patent Foundation Isolated t cell receptors and methods of use therefor
GB201710973D0 (en) 2017-07-07 2017-08-23 Avacta Life Sciences Ltd Scaffold proteins
US20220275043A1 (en) 2018-07-17 2022-09-01 Massachusetts Institute Of Technology Soluble multimeric immunoglobulin-scaffold based fusion proteins and uses thereof
WO2020112904A1 (en) 2018-11-26 2020-06-04 Massachusetts Institute Of Technology Compositions and methods for immune tolerance
WO2021074695A1 (en) 2019-10-16 2021-04-22 Avacta Life Sciences Limited PD-L1 INHIBITOR - TGFβ INHIBITOR BISPECIFIC DRUG MOIETIES.
GB202101299D0 (en) 2020-06-09 2021-03-17 Avacta Life Sciences Ltd Diagnostic polypetides and methods
WO2022043686A1 (en) 2020-08-25 2022-03-03 Thrombosis Research Institute Vaccine
GB2606693A (en) 2021-04-08 2022-11-23 Exosis Inc Fusion protein
WO2022234003A1 (en) 2021-05-07 2022-11-10 Avacta Life Sciences Limited Cd33 binding polypeptides with stefin a protein
GB202107057D0 (en) 2021-05-18 2021-06-30 Univ York Glycosylation method
EP4412711A1 (de) 2021-10-07 2024-08-14 Avacta Life Sciences Limited Serumhalbwertszeiterweiterte pd-l1-bindende polypeptide
EP4413038A1 (de) 2021-10-07 2024-08-14 Avacta Life Sciences Limited Pd-l1-bindende affimere
WO2023153876A1 (ko) 2022-02-10 2023-08-17 주식회사 아피셀테라퓨틱스 Cd40l에 특이적으로 결합하는 스테핀 a 단백질 변이체 및 이의 용도
WO2023218243A1 (en) 2022-05-12 2023-11-16 Avacta Life Sciences Limited Lag-3/pd-l1 binding fusion proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5173414A (en) * 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
GB9027917D0 (en) * 1990-12-21 1991-02-13 Ici Plc Expression systems
US5631162A (en) * 1993-06-11 1997-05-20 Massachusetts Institute Of Technology Retroviral vectors for transducing β-globin gene and β-locus control region derivatives
WO1995032299A1 (en) * 1994-05-20 1995-11-30 The Board Of Trustees Of The Leland Stanford Junior University An autonomous replication system for mammalian cells
US6110666A (en) * 1994-06-09 2000-08-29 Medical Research Council Locus control subregions conferring integration-site independent transgene expression abstract of the disclosure
AU4594996A (en) * 1994-11-30 1996-06-19 Chiron Viagene, Inc. Recombinant alphavirus vectors

Also Published As

Publication number Publication date
PT918874E (pt) 2001-08-30
WO1998007876A2 (en) 1998-02-26
EP0918874B1 (de) 2001-03-07
WO1998007876A3 (en) 1998-04-16
AU4020997A (en) 1998-03-06
JP2000516472A (ja) 2000-12-12
DK0918874T3 (da) 2001-05-14
CA2263796A1 (en) 1998-02-26
EP0918874A2 (de) 1999-06-02
ES2157084T3 (es) 2001-08-01
AU725474B2 (en) 2000-10-12
ATE199570T1 (de) 2001-03-15
DE69704206T2 (de) 2001-08-30
GR3035838T3 (en) 2001-08-31

Similar Documents

Publication Publication Date Title
DE69704206D1 (de) Selbst-replizierende episomale expressionsvektoren, welche gewebespezifische expression vermitteln
EP1176195A4 (de) VERFAHREN ZUR KONTROLLE DER AKTIVITäT VON IMMUNOLOGISCH FUNKTIONELLEM MOLEKüL
DK0939763T3 (da) Styret skift-medieret DNA-rekombination
AU7826491A (en) Novel bacillus thuringiensis microbes active against nematodes, and genes encoding novel nematode-active toxins cloned from bacillus thuringiensis isolates
PT805822E (pt) Eritropoietina seca por pulverizacao
DE69434663D1 (de) Nukleotid-sequenzen zur kontrolle der exprimierung von dns-sequenzen in einem zellulärem wirt
DE69736502D1 (de) Verstärkungsregler
AU3938397A (en) Artificial promoter libraries for selected organisms and promoters derived from such libraries
CY1108688T1 (el) Μυκητοκτονα μειγματα στη βαση ενωσεων αμιδιου
AU2002230691A1 (en) Putrescine-n-methyltransferase promoter
DE69818097D1 (de) Rückkopplungdruck- regelsystem für gleitringdichtung
EP0826966A3 (de) Methode zur Stabilisierung von Plättchen
EP0608696A3 (en) Heterologous signal sequences for secretion of insect controlling proteins.
EP0654084A4 (de) Molekulare klonierung der für die kollagennaseproduktion in clostridium histolyticum verantwortlichen gene.
EP1010761A4 (de) Gen
AU689803B2 (en) Plant-derived phospholipase D gene
AU1581397A (en) Novel tumor suppressor gene, dpc4
AU2744995A (en) Expression control polynucleotides derived from spliceosomal protein gene promoters
ATE371032T1 (de) Methoden und materialien fur genexpression
WO1998044099A3 (fr) Methodes de detection d'interactions entre plusieurs proteines
AU1932497A (en) Gene promoter sequence from banana
ATE125300T1 (de) Kontrolle der anhäufung von abweichenden expressionsvektoren während der fermentationsverfahren.
DE69723940D1 (de) Verstärkungsregler
WO2000003010A3 (en) Protein secretion from bacteria having reduced expression of a product encoded by the dlt operon
AU690974B2 (en) Polymorphs A and B of 1-(diphenylmethyl)-4- 3-(2-phenyl-1,3- dioxolan-2-yl)propyl piperazine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee